Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72603-310

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72603-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs 10mg 1000s Bottle Label)

This information provides details about a film-coated tablet containing Cyclobenzaprine Hydrochloride. The tablets are manufactured by Northstar Rx LLC in Memphis, TN, and Rubicon Research Ltd. in Thane, India. The NDC number is 72603-312-03. The text also includes storage instructions, dosage information, information about child-resistant closures, and precautions about keeping the medication out of reach of children. Manufacturing and expiration dates are also provided, along with the manufacturer's license number KD-682.*

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs 10mg 100s Bottle Label)

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs 10mg 500s Bottle Label)

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs 5mg 100s Bottle Label)

This text is from a medication label for Cyclobenzaprine Hydrochloride tablets, each containing 5 mg of the active ingredient. The usual dosage information is not provided, and it is advised to refer to the accompanying prescribing information. The tablets should be stored in a tightly closed, light-resistant container and kept at controlled room temperature. The medication should be kept out of reach of children, and the expiration date is July 2024. The tablets are manufactured for Northstar Rx LLC in Memphis, TN, and manufactured by Rubicon Research Ltd. in India. The product is distributed in a container of 100 tablets.*

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs 5mg 500s Bottle Label)

This text provides information about a medication containing Cyclobenzaprine hydrochloride in film-coated tablets. It includes dosage instructions, storage recommendations, and details about the manufacturer. The text also mentions the need to keep the medication in a child-resistant container and away from children.*

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs 7pt5mg 100s Bottle Label)

The text provides details about Cyclobenzaprine Hydrochloride Tablets, USP, with 100 tablets in the container. Each film-coated tablet contains 7.5 mg of Cyclobenzaprine hydrochloride USP. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F). The medication should be kept in a tightly closed, light-resistant container with a child-resistant closure. It also includes information on the manufacturer, dosage instructions, and precautions to keep the medicine out of the reach of children.*

FDA Label Image

Image Description (Cyclobenzaprine HCl Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.